- Multiplexed qualitative assay that allows determining the presence of 3 SARS-CoV-2 targets and one human endogenous target by studying two multiplexed rRT-PCR reactions.
- The human endogenous gene, RNaseP, allows evaluating the process of obtaining the respiratory sample, the quality of the sample and the process of extracting nucleic acids.
- Detection Limit: 20 copies (FDA Acceptance Criteria)
- Genomic inclusiveness: In silico design based on 3,123 genomes (GISAID)
- It complies with the quality requirements specified by ISO 13485 and ISO 14001 in relation to the materials used in its manufacturing process.
- For in vitro diagnostic use.
Description
Detection of SARS-CoV-2 coronavirus in respiratory samples by detecting the E, S and ORF1ab genes and the endogenous human RNaseP gene by real-time reverse transcription (rRT-PCR)
Format
96 rxn
Technology
Reverse transcription in real time
Reference
IMG-376
Compatible equipment
7500 FAST Real-Time PCR System (ThermoFisher), QuantStudio 5 Real-Time PCR System (ThermoFisher)
Imegen SARS-CoV-2 Plus RNaseP is a real-time reverse transcription PCR test intended for the qualitative detection of extracted SARS-CoV-2 RNA in nasal swab, nasopharyngeal swab, and oropharyngeal swab specimens collected from the upper respiratory tract. of individuals suspected of having COVID-19 by their medical specialist.
- Sample type: RNA purified from respiratory samples
- Required sample amount: 6 µL
- Number of reactions per sample: 1
- Number of targets: 4
- Manual working time: 10 – 30 min
- Duration of the rRT-PCR program: 1h 20 min
- Supported Platforms: 7500 FAST Real-Time PCR System (ThermoFisher Scientific), QuantStudio 5 Real-Time PCR System (ThermoFisher Scientific)
Related kits
Imegen-SARS-CoV-2 Plus RNaseP
Fill in the form to request this kit.
Call us at +34 963 212 340Or write to us at info@healthincode.com
